Part 2: Ischemic Stroke: Evaluation, Treatment, and Prevention

Matthew Brandon Maas, MD, and Joseph E. Safdieh, MD

Dr. Maas is a fellow in Stroke and Neurocritical Care, Harvard Medical School, Departments of Neurology, Massachusetts General and Brigham and Women’s Hospitals, Boston, MA. Dr. Safdieh is an assistant professor of neurology, Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, NY.

Question 7

Further cardiac evaluation shows stenotic lesions in 2 coronary arteries. Coronary artery bypass grafting (CABG) is recommended. A decision is made to allow the patient time for rehabilitation and to reassess whether he remains a good candidate for CABG based on his functional status 3 months later. His cardiologist recommends treatment with an antiplatelet medication for his coronary artery disease in the meanwhile.
Which of the following treatment regimens is best for this patient?

  •  Warfarin with a goal INR of 2-3
  •  Warfarin with a goal INR of 2-3 and aspirin 81 mg daily
  •  Warfarin with a goal INR of 1.7-2.5 and aspirin 81 mg daily
  •  Aspirin 325 mg daily
  •  Clopidogrel 75 mg daily and aspirin 81 mg daily

Updated 12/03/2014 • jdw | Copyright ©2018 Turner White Communications